# Virtonomy

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/virtonomy

- Industry: Software
- Headquarters: Munich, Germany
- Website: www.virtonomy.io
- Latest round: Seed (Apr 15, 2021)
- Investors on record: 4

## About

Based in Germany, Virtonomy GmbH develops innovative virtual patient technologies to facilitate medical device testing and development, streamlining processes and enhancing regulatory compliance for manufacturers.Virtonomy GmbH is a technology firm specializing in virtual patient simulations, headquartered in Munich, Germany. Founded in 2019 by Laetitia Wandtke, Simon Sonntag, and Wen Chu, the company has completed 2 funding deals, with the most recent being a Seed 2 round on February 15, 2023, where they raised EUR 3.5 million from investors including Accenture Technology Ventures, Bayern Kapital, and Dieter von Holtzbrinck Ventures. The company is led by CEO Simon Sonntag.Virtonomy GmbH specializes in the development of virtual patient technologies, primarily through its flagship product, v-Patients. This advanced digital twin and simulation solution enables medical device developers to conduct tests and develop products in a virtual environment, streamlining the product life cycle from concept to regulatory reporting. By utilizing an extensive database of real clinical data, v-Patients accurately reflects anatomical variability, demographic diversity, and pathological conditions. The platform serves a wide range of medical devices, including heart valves, total artificial hearts, occluders, catheters, cannulas, and stents, effectively reducing the risks, expenses, and regulatory burdens typically associated with medical device development. Virtonomy’s services are primarily targeted at clients in Europe and North America, including medical device manufacturers and regulatory bodies seeking innovative solutions to enhance product safety and performance in cardiovascular technologies.Virtonomy's revenue model is predicated on providing access to its v-Patients platform through subscription-based transactions and partnerships with medical device manufacturers. Clients typically engage with the firm to customize their virtual testing plans, which includes comprehensive regulatory consultation services aimed at ensuring compliance with evolving guidelines. The structure of transactions often involves tailored workshops and support for clients, where Virtonomy offers its regulatory expertise free of charge during initial consultations. Pricing plans for the services are determined based on the specific needs of the client, with various levels of service offering different features and support. This flexible approach allows clients to optimize their device development processes effectively while leveraging the benefits of in silico testing methods.In February 2023, Virtonomy GmbH raised EUR 3.5 million in Seed 2 funding, co-led by Bayern Kapital and Dieter von Holtzbrinck Ventures, with participation from Accenture Technology Ventures and other investors. The company will utilize the funding to expand its capabilities to medical technology companies globally, aiming to introduce new products and enhance services tailored to client needs. Specific plans for expansion into new markets and regions have not been detailed, but the funding signifies a commitment to growth and innovation in the medical device industry.

## Funding rounds

- Seed, Apr 15, 2021 — Bayern Kapital, Plug and Play, Dieter von Holtzbrinck Ventures, UnternehmerTUM Initiative For Industrial Innovators

## Investors

- Bayern Kapital (https://capitalatlas.ai/funds/bayern-kapital) — Seed
- Plug and Play (https://capitalatlas.ai/funds/plug-and-play) — Seed
- Dieter von Holtzbrinck Ventures (https://capitalatlas.ai/funds/dieter-von-holtzbrinck-ventures) — Seed
- UnternehmerTUM Initiative For Industrial Innovators — Seed